What is BioCryst Pharmaceuticals's capex?

BioCryst Pharmaceuticals (BCRX) reported capex of $403K in Q1 2026.

How has BioCryst Pharmaceuticals's capex changed year-over-year?

BioCryst Pharmaceuticals's capex increased by 181.8% year-over-year, from $143K to $403K.

What is the long-term trend for BioCryst Pharmaceuticals's capex?

Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's capex has grown at a 0.9% compound annual growth rate (CAGR), from $2.39M to $2.47M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

BioCryst Pharmaceuticals BCRX CapEx

CapEx at other companies

Ionis PharmaceuticalsIONS

$21.76M+73.0%

Ultragenyx PharmaceuticalRARE

$1M0.0%

ANI PharmaceuticalsANIP

$6.07M+146%

AnaptysBio, Inc.ANAB

$17K-51.4%

BridgeBio PharmaBBIO

$69K—

Arrowhead ResearchARWR

$2.57M-51.6%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's capex?: BioCryst Pharmaceuticals (BCRX) reported capex of $403K in Q1 2026.
How has BioCryst Pharmaceuticals's capex changed year-over-year?: BioCryst Pharmaceuticals's capex increased by 181.8% year-over-year, from $143K to $403K.
What is the long-term trend for BioCryst Pharmaceuticals's capex?: Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's capex has grown at a 0.9% compound annual growth rate (CAGR), from $2.39M to $2.47M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.